A Phase 2 Study of Postoperative Xevinapant and Chemoradiation for Patients With High-Risk Resected Head and Neck Squamous Cell Carcinomas

International Journal of Radiation Oncology, Biology, Physics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles